Long-term Benefit of PD-L1 Blockade in Lung Cancer Associated with JAK3 Activation

Title
Long-term Benefit of PD-L1 Blockade in Lung Cancer Associated with JAK3 Activation
Authors
Keywords
-
Journal
Cancer Immunology Research
Volume 3, Issue 8, Pages 855-863
Publisher
American Association for Cancer Research (AACR)
Online
2015-05-27
DOI
10.1158/2326-6066.cir-15-0024

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started